Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols
出版年份 2012 全文链接
标题
Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols
作者
关键词
-
出版物
FASEB JOURNAL
Volume 27, Issue 1, Pages 199-207
出版商
FASEB
发表日期
2012-10-17
DOI
10.1096/fj.12-211896
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Amyloid- Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3 in Primary Cultured Hippocampal Neurons
- (2013) H. Decker et al. JOURNAL OF NEUROSCIENCE
- Inhibition of Choline Acetyltransferase as a Mechanism for Cholinergic Dysfunction Induced by Amyloid-β Peptide Oligomers
- (2012) Nilson Nunes-Tavares et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease
- (2011) Kyle C. Wilcox et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Two Distinct Amyloid β-Protein (Aβ) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses
- (2011) Satoko Matsumura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid: Little proteins, big clues
- (2011) Jim Schnabel NATURE
- Sodium/myo-Inositol Transporters: Substrate Transport Requirements and Regional Brain Expression in the TgCRND8 Mouse Model of Amyloid Pathology
- (2011) Daniela Fenili et al. PLoS One
- Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain
- (2010) Anutosh Chakraborty et al. CELL
- Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors
- (2010) Elena Alberdi et al. CELL CALCIUM
- Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
- (2010) Kyle D. Copps et al. Cell Metabolism
- Alzheimer disease prevention: Focus on cardiovascular risk, not amyloid?
- (2010) D. S. GELDMACHER CLEVELAND CLINIC JOURNAL OF MEDICINE
- Chronic treatment with d-chiro-inositol prevents autonomic and somatic neuropathy in STZ-induced diabetic mice
- (2010) V. X. Farias et al. DIABETES OBESITY & METABOLISM
- Small moleculeβ-amyloid inhibitors that stabilize protofibrillar structuresin vitroimprove cognition and pathology in a mouse model of Alzheimer’s disease
- (2010) Cheryl A. Hawkes et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Unknown
- (2010) Joseph Larner et al. MOLECULAR MEDICINE
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- (2010) Jorge J Palop et al. NATURE NEUROSCIENCE
- Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
- (2010) Marianne Renner et al. NEURON
- ADDLs and the signaling web that leads to Alzheimer’s disease
- (2010) Grant A. Krafft et al. NEUROPHARMACOLOGY
- Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A deposition in an Alzheimer mouse model with diabetes
- (2010) S. Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport: Fig. 1
- (2010) Keith A. Vossel et al. SCIENCE
- Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice
- (2009) Corinne G. Jolivalt et al. EXPERIMENTAL NEUROLOGY
- Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
- (2009) Wei-Qin Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption
- (2009) Wei-Qin Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory Behaviors
- (2009) D. R. Marks et al. JOURNAL OF NEUROSCIENCE
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
- (2009) Shaomin Li et al. NEURON
- Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
- (2009) Fernanda G. De Felice et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alzheimer's-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal
- (2009) Jason Pitt et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
- (2008) Giulio Maria Pasinetti et al. JOURNAL OF NEUROCHEMISTRY
- Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation
- (2008) April J. Stull et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
- Amyloid beta oligomers induce impairment of neuronal insulin receptors
- (2007) Wei-Qin Zhao et al. FASEB JOURNAL
- Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
- (2007) Fernanda G. De Felice et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started